Albumin should be given after paracentesis when more than 5 liters of ascitic fluid are removed. This is the threshold established by the 2021 American Association for the Study of Liver Diseases (AASLD) Practice Guidance, and it’s backed by strong evidence showing that skipping albumin above this volume leads to a dangerous drop in circulatory function. Below 5 liters, albumin is generally not required, though there are nuances worth understanding.
Why 5 Liters Is the Cutoff
Removing large volumes of fluid from the abdomen doesn’t just drain liquid. It triggers a chain of cardiovascular changes known as post-paracentesis circulatory dysfunction, or PICD. When pressure inside the abdomen drops suddenly, blood vessels dilate, cardiac output shifts, and the body’s ability to maintain normal blood pressure becomes compromised. The kidneys respond by activating stress hormones, particularly the renin-angiotensin system, which over time worsens fluid retention and can damage kidney function.
Several volume expanders have been tested to prevent this, including saline, dextran, and synthetic starches. Albumin consistently outperforms all of them when the volume removed exceeds 5 liters. It reduces the incidence of PICD, lowers the risk of kidney injury and dangerously low sodium levels, and improves survival. Below 5 liters, the circulatory stress is usually mild enough that the body compensates on its own.
How Much Albumin to Give
The standard recommendation is 6 to 8 grams of albumin for every liter of fluid removed beyond 5 liters. In practice, this is often simplified into tiered doses: 25 grams for 5 to 6 liters removed, 50 grams for 7 to 10 liters, and 75 grams for more than 10 liters. These standardized ranges make ordering easier and reduce dosing errors.
Some evidence suggests that a lower dose of 4 grams per liter achieves similar clinical outcomes. One quality improvement study found no change in safety when the average dose decreased from 8.3 to 6.7 grams per liter. Still, most guidelines stick with the 6 to 8 gram range as the default recommendation.
The 25% concentration is preferred over the 5% solution. Because it’s more concentrated, it pulls fluid from tissues into the bloodstream rather than adding extra volume, and it reaches therapeutic levels faster with a smaller infusion. This matters for patients who already have fluid overload.
Timing of the Infusion
Albumin is given after the paracentesis is complete, not before or during the procedure. The infusion typically starts once all the fluid has been drained. There is no benefit to delaying it by hours or days. The goal is to counteract the circulatory changes that begin as soon as the abdominal pressure drops, so prompt administration is important.
What Happens Below 5 Liters
For small-volume paracentesis, albumin is not routinely recommended. But “not required” is not the same as “never helpful.” Research on patients with refractory ascites who use indwelling drains at home has revealed an important nuance: draining 1.5 liters or more per day without albumin was associated with higher rates of acute kidney injury and low sodium compared to draining less than 1.5 liters daily. Patients draining under 1.5 liters per day had complication rates comparable to those receiving standard large-volume paracentesis with albumin.
This suggests that cumulative daily drainage matters, not just single-session volume. If you’re using a long-term drain and removing more than 1.5 liters a day, the question of albumin replacement is worth discussing with your care team, even though formal guidelines don’t yet address this scenario in detail.
What Albumin Actually Prevents
The most immediate risk albumin prevents is PICD, which develops in 60 to 80% of patients who undergo large-volume paracentesis without volume expansion. PICD doesn’t always cause obvious symptoms right away, but it sets off a cascade that worsens kidney function over days to weeks.
The most serious downstream consequence is hepatorenal syndrome, a form of kidney failure driven by the same circulatory dysfunction. In patients with spontaneous bacterial peritonitis (a common infection in ascites), albumin reduced the incidence of hepatorenal syndrome by 66%, from 33% down to 10%. In-hospital mortality dropped from 29% to 10%, and three-month mortality fell from 41% to 22%. While those numbers come from infection-related albumin use rather than paracentesis specifically, they illustrate how powerfully albumin protects kidney function in patients with advanced liver disease.
Large-volume paracentesis without albumin is explicitly listed alongside infection and bleeding as one of the major precipitating factors for hepatorenal syndrome. This is not a minor omission. For patients with cirrhosis and tense ascites, albumin after large-volume paracentesis is one of the few interventions with clear mortality benefit.